EVARREST® Fibrin Sealant Patch: Clinical Trials

2 trials of EVARREST® Fibrin Sealant Patch, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2

Follow EVARREST® Fibrin Sealant Patch: new trials by email Literature Review of EVARREST® Fibrin Sealant Patch trials Research Report on EVARREST® Fibrin Sealant Patch

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The EVARREST® Pediatric Mild or Moderate Liver and Soft Tissue Bleeding Study
EVARREST® Fibrin Sealant Patch - Controlling Mild to Moderate Bleeding During Surgery
Phase 3CompletedEthicon, Inc.352018-03-202026-04-08
The EVARREST® Fibrin Sealant Patch Liver Study
EVARREST® Fibrin Sealant Patch, Standard of Care (SoC) - Hemorrhage
Phase 3CompletedEthicon, Inc.1022013-10-012016-07-11

Conditions studied

Hemorrhage (2)

Sponsors

Ethicon, Inc. (2)

Countries

United Kingdom (2)  ·  United States (2)  ·  Australia (1)  ·  New Zealand (1)

Top investigators

Richard Kocharian, MD (1)

Results publications

PMID 26636489, PMID 27017161